ArticleBioengineered2021

RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.

Fei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.